Insurers still overlook breast cancer screening

Article

This year's annual report from the National Committee for Quality Assurance showed a mixed bag of good and bad news, reported Managed Care (11/2005). Of the 289 commercial health plans that reported data to the NCQA, the average performance showed improvements in 18 of 22 clinical measures.

This year's annual report from the National Committee for Quality Assurance showed a mixed bag of good and bad news, reported Managed Care (11/2005). Of the 289 commercial health plans that reported data to the NCQA, the average performance showed improvements in 18 of 22 clinical measures. First the bad news: The average performance of the health plans worsened with respect to breast cancer screening. On the other hand, the clinical measures that did show improvement included beta-blocker treatment after a heart attack, comprehensive diabetes care, cholesterol management control, high blood pressure control, and childhood immunization status.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Recent Videos
Ousseny Zerbo, PhD, highlights benefits of influenza vaccination during pregnancy | Image Credit: divisionofresearch.kaiserpermanente.org.
Michael Ussher, PhD, highlights the benefits of vaping over smoking in pregnancy | Image Credit: sgul.ac.uk.
Neal Barnard, MD, FACC, highlights AMA's new breast cancer prevention guidelines | Image Credit: pcrm.org.
Zachary Wagner, PhD, discusses the harms of bias in reproductive care | Image Credit: ornsife.usc.edu.
Related Content
© 2025 MJH Life Sciences

All rights reserved.